Exploring Big Data in Hematological Malignancies: Challenges and Opportunities

被引：1
|
作者：
Westin, Gustavo F. [1 ]
Dias, Ajoy L. [1 ]
Go, Ronald S. [1 ]
机构：
[1] Mayo Clin, Div Hematol, 200 First St SW, Rochester, MN 55905 USA
来源：
CURRENT HEMATOLOGIC MALIGNANCY REPORTS | 2016年 / 11卷 / 04期
关键词：
Acute myeloid leukemia; Hodgkin lymphoma; Diffuse large B cell lymphoma; Multiple myeloma; Amyloidosis; Hematopoietic stem cell transplantation; CHRONIC LYMPHOCYTIC-LEUKEMIA; STEM-CELL TRANSPLANTATION; CHEMOTHERAPY PLUS RITUXIMAB; STAGE HODGKINS LYMPHOMA; ACUTE MYELOID-LEUKEMIA; HIGH-DOSE MELPHALAN; HEALTH-CARE-SYSTEM; MULTIPLE-MYELOMA; ELDERLY-PATIENTS; UNDETERMINED SIGNIFICANCE;
D O I：
10.1007/s11899-016-0331-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Secondary analysis of large datasets has become a useful alternative to address research questions outside the reach of clinical trials. It is increasingly utilized in hematology and oncology. In this review, we provided an overview of some examples of commonly used large datasets in the USA and described common research themes that can be pursued using such a methodology. We selected a sample of 14 articles on adult hematologic malignancies published in 2015 and highlighted their contributions as well as limitations.
引用
收藏
页码：271 / 279
页数：9
相关论文
共 50 条
  • [1] Exploring Big Data in Hematological Malignancies: Challenges and Opportunities
    Gustavo F. Westin
    Ajoy L. Dias
    Ronald S. Go
    Current Hematologic Malignancy Reports, 2016, 11 : 271 - 279
  • [2] CAR-T Cell Therapy in Hematological Malignancies: Current Opportunities and Challenges
    Zhang, Xiaomin
    Zhu, Lingling
    Zhang, Hui
    Chen, Shanshan
    Xiao, Yang
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [3] Exploring Old Drugs for the Treatment of Hematological Malignancies
    Gan, F.
    Cao, B.
    Wu, D.
    Chen, Z.
    Hou, T.
    Mao, X.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (10) : 1509 - 1514
  • [4] Inhibitor of Apoptosis (IAP) proteins in hematological malignancies: molecular mechanisms and therapeutic opportunities
    Fulda, S.
    LEUKEMIA, 2014, 28 (07) : 1414 - 1422
  • [5] Deubiquitinases in hematological malignancies
    Lei, Hu
    Wang, Jiaqi
    Hu, Jiacheng
    Zhu, Qian
    Wu, Yingli
    BIOMARKER RESEARCH, 2021, 9 (01)
  • [6] Applications of monoclonal antibodies for the treatment of hematological malignancies
    Migkou, Magda
    Dimopoulos, Meletios-Athanassios
    Gavriatopoulou, Maria
    Terpos, Evangelos
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (02) : 207 - 220
  • [7] Theranostic Potentials of Gold Nanomaterials in Hematological Malignancies
    Shakil, Md Salman
    Niloy, Mahruba Sultana
    Mahmud, Kazi Mustafa
    Kamal, Mohammad Amjad
    Islam, Md Asiful
    CANCERS, 2022, 14 (13)
  • [8] Challenges in vaccine therapy in hematological malignancies and strategies to overcome them
    Nahas, Myrna R.
    Avigan, David
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (09) : 1093 - 1104
  • [9] Exploring the nexus of nuclear receptors in hematological malignancies
    Manickasamy, Mukesh Kumar
    Sajeev, Anjana
    BharathwajChetty, Bandari
    Alqahtani, Mohammed S.
    Abbas, Mohamed
    Hegde, Mangala
    Aswani, Babu Santha
    Shakibaei, Mehdi
    Sethi, Gautam
    Kunnumakkara, Ajaikumar B.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2024, 81 (01)
  • [10] WNT Signaling in Hematological Malignancies
    Frenquelli, Michela
    Tonon, Giovanni
    FRONTIERS IN ONCOLOGY, 2020, 10
12345